This inventor holds 6 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 4 EPO patents. Top assignees: Leland Stanford Junior University, The United States of America, as Represented by the Secretary, Department of Health and Human Services, University of California. Active years: 2017-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
6 out of 5,515 
6 out of 3,697 
6 out of 16,035 
Years Active: 2017-2025
Title: The Innovations of Kim J. Hasenkrug
Introduction
Kim J. Hasenkrug, an esteemed inventor based in Victor, Montana, has made significant contributions to the field of medical science through his innovative patents. With a total of five patents attributed to his name, Hasenkrug focuses on groundbreaking therapies targeting infectious diseases, showcasing a strong commitment to advancing healthcare.
Latest Patents
Among Hasenkrug's latest contributions are his patents related to CD47 targeted therapies for the treatment of infectious diseases. These methods provide novel approaches for treating subjects with intracellular pathogen infections. Specifically, they involve administering an agent that reduces the binding of CD47 on an infected cell to SIRPα on a host phagocytic cell. The effective dosage administered aims to enhance the phagocytosis of infected cells, which represents a significant breakthrough in therapeutic strategies against these stubborn infections.
Career Highlights
Throughout his career, Hasenkrug has been affiliated with prestigious academic institutions such as Leland Stanford Junior University and the University of California. His extensive research and dedication to the field have positioned him as a prominent figure in the development of innovative medical treatments.
Collaborations
Kim J. Hasenkrug has collaborated with several esteemed colleagues in his research endeavors, including Kipp Andrew Weiskopf and Cheryl A. Stoddart. These collaborations not only highlight his ability to work in diverse team settings but also underline the collective effort that drives innovation in medical science.
Conclusion
In summary, Kim J. Hasenkrug stands out as a noteworthy inventor whose work in CD47 targeted therapies demonstrates the intersection of innovative thought and practical application in treating infectious diseases. His collaborations and associations with leading research institutions further enhance his contributions, paving the way for future advancements in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile